Gene Therapy

Browse venture capital firms focused on Gene Therapy.

Explore VC firms that invest in Gene Therapy. Filter by country and stage to refine results.

6 of 1354 firms
Filters:
4BIO Capital favicon
4BIO Capital
United Kingdom

4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. It invests in, supports, and grows early-stage companies developing treatments in areas of high unmet medical need. The firm's team comprises leading advanced therapy scientists and experienced life science investors.

Founded 2014
Investment Stages
Series A
Series B
Markets
Gene Therapy
Cell Therapy
RNA-based Therapy
Targeted Therapies
Microbiome
CincyTech favicon
CincyTech
United States

CincyTech is a venture capital firm that invests in innovative founders tackling the world's complex challenges. Their experienced team partners early to help transform ideas into world-class companies.

Founded 2006
Investment Stages
Series A
Series B
Markets
Therapeutics
SaaS
Precision Medicine
Medical Device
Infrastructure
Gene Therapy
FinTech
EdTech
Digital Health
Diagnostics
Data Management
Consumer Digital
Advanced Materials
AdTech
AI / ML
Jeito Capital favicon
Jeito Capital
France

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.

Founded 2018
Investment Stages
Series A
Series B
Markets
Biopharmaceuticals
Oncology
Ophthalmology
Rare Skeletal Diseases
Severe Respiratory Diseases
Fibrosis
Immuno-oncology
Cardiovascular Disease
Immuno-Oncology Therapies
Auto-Immune Diseases
Neuromuscular Diseases
Cell Therapy
Gene Therapy
Sanofi Ventures favicon
Sanofi Ventures
United States, France

Sanofi Ventures is the corporate venture capital arm of Sanofi. They invest in top-tier biotech and digital health companies focusing on improving patient care and transforming healthcare. Their investments span from Seed to Series B and beyond, offering portfolio companies access to Sanofi's expertise.

Founded 2001
Investment Stages
Seed
Series A
Series B
Markets
Biotherapeutic
Digital Health
Rare diseases
Immunology and inflammation
Oncology
Cell and gene therapy
Vaccines
Data science
Syncona favicon
Syncona
United Kingdom, Guernsey

Syncona is a FTSE250 company focused on founding, building, and funding healthcare companies. They aim to deliver transformational treatments for patients in areas of high unmet need, building a diversified portfolio of 20-25 globally leading life science businesses.

Founded 2012
Investment Stages
Series A
Series B
Series C
Markets
Oncology
Ophthalmology
Cell therapy
Gene therapy
Renal
Cardioprotection
Immunology
Rare diseases
Vsquared Ventures favicon
Vsquared Ventures
Germany

Vsquared Ventures invests in transformative technologies and entrepreneurs. They focus on backing companies with conviction, even when facing technological risks, and support their growth to scale their vision. Their portfolio includes companies across diverse sectors like aerospace, quantum computing, and biotechnology.

Founded 2020
Investment Stages
Pre-Seed
Seed
Markets
Aerospace
Semiconductors
Quantum Computing
Robotics
Neurotechnology
Space Exploration
Green Hydrogen
Laser Technology
Data Management
Gene Therapy
Software
AI
Photonics
Autonomous Driving
Cloud Engineering
Battery Technology
Microsatellites
Microfluidics